Pd-l1 Ihc 22c3 Pharmdx

Recall Summary The PD-L1 IHC 22C3 PHARMDX diagnostic test kit is being recalled in Canada due to a manufacturing issue that could affect the accuracy of test results. This test is used to help determine treatment options for certain cancer patients. The recall affects all batches of this product distributed across Canada.

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DEVICES

Recall date

2016-12-05

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/be02290b-c800-4310-9b70-5fb96109382f